On November 7, 2023 Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, reported that Company’s Management will participate in upcoming investor conferences in November (Press release, Viracta Therapeutics, NOV 7, 2023, View Source [SID1234637178]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details on the conferences can be found below:

Stifel 2023 Healthcare Conference
Presentation Date: Wednesday, November 15, 2023
Presentation Time: 10:20 – 10:50 AM ET

Piper Sandler 35th Annual Healthcare Conference
Presentation Date: Tuesday, November 28, 2023
Presentation Time: 12:10 – 12:30 PM ET

6th Annual Evercore ISI HealthCONx Conference
Presentation Date: Wednesday, November 29, 2023
Presentation Time: 3:25 – 3:45 PM ET

A live webcast of the presentation will be available on the Investors section of the Viracta website under "Events and Webcasts" and archived for 90 days.